Pfizer Earnings, Revenue miss in Q4 By Investing.com

Pfizer (NYSE:PFE) reported on Tuesday fourth quarter earnings that missed analysts’ forecasts and revenue that fell short of expectations.

Pfizer announced earnings per share of $0.42 on revenue of $11.68B. Analysts polled by Investing.com anticipated EPS of $0.5183 on revenue of $12.24B.

Pfizer shares are down 2% from the beginning of the year and are trading at $35.80 , down-from-52-week-high.They are under-performing the S&P Global 100 which is up 1.24% from the start of the year.

Pfizer follows other major Healthcare sector earnings this month

Pfizer’s report follows an earnings beat by J&J on January 26, who reported EPS of $1.86 on revenue of $22.48B, compared to forecasts EPS of $1.82 on revenue of $21.66B.

Abbott Labs had beat expectations on January 27 with fourth quarter EPS of $1.45 on revenue of $10.7B, compared to forecast for EPS of $1.35 on revenue of $9.94B.

Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com’s earnings calendar